Position in TGTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,875,344
-$9,441,378 QoQ
Shares Held
116,657
-73.9% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Derivatives in TGTX
reported options exposure · as of Jun 30, 2024CallValue
$878,826
CallShares
49,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,145,056 across 362 Biotechnology names. TGTX ranks #49 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in TGTX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,875,344 | 116,657 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $13,316,722 | 446,720 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,553,377 | 458,225 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $22,333,449 | 620,546 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $9,979,495 | 253,094 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $9,558,646 | 317,563 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $8,117,663 | 347,057 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $2,478,751 | 139,334 | Shares | Sole | 2026-03-23 | |
| 2024-06-30 | $878,826 | 49,400 | Call | Sole | 2026-03-23 | |
| 2024-03-31 | $2,378,539 | 156,380 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $7,310,462 | 428,013 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $3,658,686 | 437,642 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $11,999,756 | 483,082 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $11,882,998 | 790,093 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $6,103,901 | 515,968 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $2,296,203 | 194,100 | Call | Sole | 2026-03-30 | |
| 2022-09-30 | $3,505,403 | 592,129 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $1,401,518 | 329,769 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,334,166 | 140,291 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,149,505 | 218,395 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $3,335,687 | 100,231 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $955,900 | 24,643 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,847,093 | 121,309 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $3,183,050 | 61,189 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $12,898,747 | 482,016 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $17,998,526 | 923,949 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $8,471,442 | 860,919 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||